Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia.
about
Emerging drugs for chronic lymphocytic leukaemia.FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia.Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.Clinical implications of angiogenesis in cancers.Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence.Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia.Intracellular and Extracellular miRNAs in Regulation of Angiogenesis SignalingANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?Critical signal transduction pathways in CLL.Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells.Mechanism and Function of Angiogenin in Hematopoietic Malignancy.The microenvironment in myelodysplastic syndromes: niche-mediated disease initiation and progression.Signaling and molecular basis of bone marrow niche angiogenesis in leukemia.Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3.Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients.Ovarian carcinoma cells effectively inhibit differentiation and maturation of dendritic cells derived from hematopoietic progenitor cells in vitro.KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia.Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia.Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL).Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon?
P2860
Q30353154-82B789CB-E7C5-4805-A8C2-C266BA2B7AB5Q33416596-3E0EA856-19DF-4580-9DA2-B642FA266E92Q35070558-933DD250-5AE9-4032-BE9A-77D280EF760EQ36006453-2475C45B-4EEE-4B93-B6EF-17B637B7BD21Q36012979-7F23C06B-E34D-4259-99CB-55214CFABA79Q36617092-397B06EE-F80E-40C1-8C6F-A751C265FFA1Q36635059-939D4754-1C11-46A8-81EF-78D0D7CD9B0DQ37059771-80DDD5F2-D1A8-4519-8E3C-153A81907F3BQ37192643-3E0680C7-3F89-4F27-B494-218766B1C006Q37424750-054DCF89-0753-4133-9755-4F1C9AD2EE46Q37571068-4DED9E53-AED9-4AFF-8E1D-752136EF0294Q37591356-4A421B20-79B8-4599-804E-96723738B9BEQ38348410-D9E19173-1A9D-483D-8E84-133E2E25E720Q38366707-A67D7438-CA71-4977-A743-300AAE363B4AQ38615755-E22878E4-8DBB-45E4-8456-D92A6EBA4E13Q38689750-AFF5DCDA-3623-4131-91B9-666BF80A10ADQ39511827-2DAD3A07-2CD1-4890-A92C-3CCF40116376Q40138593-DFA5A8D1-45DB-4EA6-B77C-9340E73BC634Q40367465-0BB70DF1-C218-47FB-BD45-EB1244DB95D2Q43628585-5A1960BB-4E38-4FCD-8C18-B0E217A45667Q44497863-3ECE8A51-5347-4AEB-A0C3-5247DDDD339DQ44531920-DA098633-0427-4C5B-A098-E70A2A0F4269Q46830786-35E5C956-65A1-4219-93B1-F6AB205F9668Q47383709-24D5F9A1-A6D8-4BB0-995D-90F965DBB65DQ51774149-152A3CD5-9355-47B5-BC77-DEDCDE9010A2
P2860
Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Prognostic value of enhanced b ...... chronic lymphocytic leukemia.
@en
Prognostic value of enhanced b ...... chronic lymphocytic leukemia.
@nl
type
label
Prognostic value of enhanced b ...... chronic lymphocytic leukemia.
@en
Prognostic value of enhanced b ...... chronic lymphocytic leukemia.
@nl
prefLabel
Prognostic value of enhanced b ...... chronic lymphocytic leukemia.
@en
Prognostic value of enhanced b ...... chronic lymphocytic leukemia.
@nl
P2093
P1433
P1476
Prognostic value of enhanced b ...... chronic lymphocytic leukemia.
@en
P2093
Angelo Vacca
Antonio Cuneo
Domenico Levato
Francesco Cavazzini
Franco Dammacco
Gaetano Vitelli
Luigi Tucci
Stefano Molica
P304
P356
10.1182/BLOOD-2002-01-0084
P407
P577
2002-11-01T00:00:00Z